Our Advocacy Partners
Copyright © 2023 · All Rights Reserved · Ontario Rett Syndrome Association | O.R.S.A.
NonProfit Theme v5 by Organic Themes · WordPress Hosting · RSS Feed · Log in
Copyright © 2023 · All Rights Reserved · Ontario Rett Syndrome Association | O.R.S.A.
NonProfit Theme v5 by Organic Themes · WordPress Hosting · RSS Feed · Log in
News
Tag: Acadia
DayBue Announcement
Last Updated: 04/20/2023 by admin Leave a Comment
Acadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is Now Available for the Treatment of Rett Syndrome — Commercial launch of DAYBUE offers Rett syndrome community the first and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000… Read More
Category: News, Press Releases, Top Slider Tags: Acadia, Daybue, Treatment